This year, Avoca's research focuses on potential changes in regulatory guidance under ICH E6 (R3) to gain understanding of current awareness and perceived impacts among clinical trial stakeholders to navigate the path forward.
Access The 2024 Avoca State of the Industry Report:
Anticipating ICH E6 (R3): Awareness, Impact & Preparedness
Join us as we discuss approaches to adopt innovative feasibility and site start-up solutions.
Read MoreJanuary 10, 2025 | 11:00am – 12:00pm EST
Held the second Friday of every month and open to the industry, this webinar offers a live demonstration of the AQC Knowledge Center.
November 20, 2024 | 11:00am – 12:00pm EST
Monthly forum open exclusively to Avoca Quality Consortium members.
November 5, 2024 | 11:00am – 12:00pm EST
October 30, 2024 | 10:00am – 11:00am EDT
October 15, 2024 | 11:00am – 12:00pm EDT
October 9, 2024 | 12:00pm – 1:00pm EDT
June 16-20, 2024 | San Diego, CA
Join Avoca's Trevor Cole for the session: "Feasible Site Feasibility Assessments: Rethinking Business as Usual to Reduce Burden, Timelines, and Costs for Sustainability"
May 23, 2024 | 12:00pm – 1:00pm EDT
Explore the competitive landscape of clinical trials and how feasibility and participant recruitment and retention play a pivotal role in the success of a study.
May 14-15, 2024 | Industry-wide Virtual Event
Now in its 13th year, the AQC Summit will feature thought leaders and executive panels sharing experiences, insights, and actions to maximize time in order to modernize clinical trials.
The survey is now closed — thank you for your participation!
Avoca, a WCG company, takes pride in providing the industry with insights into trends in clinical research to optimize the execution and quality of clinical trials. This year, our survey focuses on potential changes in regulatory guidance under ICH E6 (R3). Importantly, you don’t need to be familiar […]
February 6, 2024 | 1:30pm – 3:00pm EST
Have confidence that you’re ready for successful implementation of the final R3 guidance.
January 17, 2024 | 11:00am – 12:30pm EST
The AQC is excited to kick off 2024 with a member-only meeting.
A Side-by-Side Comparison of Revisions 2 and 3 Changes to the international guideline for good clinical practice, ICH E6, are extensive, significant and scheduled to take effect in less than a year. Are you prepared to understand and implement them? ICH E6(R3), as currently published, is a completely revised guideline with no reference to […]
Read MoreHealth Care Compliance Association (HCCA) Report on Research Compliance Volume 20, Number 10 September 21, 2023 By Theresa Defino It’s not surprising that most people don’t hold informed—or strong beliefs about clinical trials—they’re what is termed “research-naïve,” meaning they have little or no personal experience with them. And so are most providers. […]
Read MoreListen in as we dive into feedback from perspectives across all clinical research stakeholders — sponsors, providers, sites, and patients.
Read MoreThis year, Avoca's research analyzes across Sponsors, Providers, Site Staff, Patients, Physicians, and Investigators to determine alignment and explore motivators and deterrents of participation in clinical trials.
Access The 2023 WCG Avoca State of the Industry Report:
A 360° Assessment of the Clinical Trial Industry
Princeton, NJ, July 12, 2023 – WCG, one of the world’s leading providers of solutions that measurably improve the quality and efficiency of clinical research, released its 2023 Avoca State of the Industry Report. The report provides a 360-degree review of what motivates or deters potential volunteers from participating in clinical trials, and what steps can be […]
Read MoreJune 25-29, 2023 | Boston, MA
Join WCG at booth 231 and for two sessions.
June 8, 2023 | 11:00am – 12:00pm EDT
In this webinar, WCG Avoca and CenterWatch 2022 industry research shines a light on the importance of site and participant relationships for sustainability of the clinical research patient and investigator pools.
The imperative to obtain a diverse body of clinical trial participants has been stressed in public statements for decades; however, parties executing clinical trials have remained insufficiently effective in addressing it. Understanding the patterns […]
Read MoreWCG's 360 Protocol Assessment™ is an integrated, turn-key solution that addresses ICH E8 R1 expectations and improves clinical trial predictability by providing sponsors with an operational risk and feasibility assessment of the protocol through the lens of multi-functional stakeholders [...]
Read MoreMay 21-24, 2023 | Philadelphia, PA
Join WCG Avoca's Trevor Cole for the session: "What to Expect When You’re Inspected: Site FDA Inspection Readiness and Logistics"
May 17-18, 2023 | Industry-wide Virtual Event
Now in its 12th year, the Summit features expert speakers, executive panels, and perspectives from all stakeholders across the clinical trial ecosystem.
The survey is closed – thank you for your participation!
WCG Avoca takes pride in providing the industry with insights into trends in clinical research to optimize the execution and quality of clinical trials. This year, our research looks to analyze across clinical research stakeholders […]
February 6-9, 2023 | Orlando, FL + Virtual
Join WCG Avoca's Kristen Bennett for the session: "Principles of RBQM Success: Why It’s Important and What Happens Without an RBQM Program"
January 24, 2023 | 2:00pm – 3:00pm EST
In addition to WCG's 2023 Clinical Research Trends & Insights report, an online panel of clinical trial experts including WCG Avoca's Cristin MacDonald, PhD, discuss the future of clinical research.
January 18, 2023 | 11:00am – 12:00pm EST
In this webinar, WCG Avoca and Medable address how the clinical trial ecosystem can work together to alleviate the site burdens that come along with DCT implementation.
With the update of the Bioresearch Monitoring Program (BIMO) Sponsors and Contract Research Organizations Compliance Program Manual, FDA provides a comprehensive overview of inspection activities with significant revisions to Part III–Inspectional section […]
Read MoreBy Ed Miseta, Chief Editor, Clinical Leader - Walgreens recently became a member of the Avoca Quality Consortium (AQC), a community dedicated to improving clinical trials […]
Read MoreOctober 20, 2022 | Boston, MA
Join us for breakfast, workshops, and face-to-face networking (AQC Member-only event).
Today, the WCG Avoca Quality Consortium (AQC) is over 200 Member companies strong, representing Sponsors, CROs, Sites, and Clinical Service Providers of all sizes. To remain true to our mission of helping our Member organizations improve efficiency, increase quality, and ensure compliance in clinical trial execution, WCG Avoca will not be increasing AQC Annual Membership […]
Read MoreOctober 4, 2022 | 11:00am – 12:30pm EDT
Read MoreSeptember 12, 2022 | San Diego, CA
Join us for lunch, workshops, and face-to-face networking (AQC Member-only event).
September 7-8, 2022 | 10:00am – 3:00pm EDT
WCG Avoca is excited to offer our first-ever virtual Vendor Days event, during which AQC Vendor Members will showcase their solutions and engage in a group setting where insights and needs will be shared among attendees.
Each year, WCG Avoca surveys industry professionals to understand trends in clinical development, with a particular focus on outsourcing dynamics and relationships between research Sponsors and Providers.
Access The 2021 WCG Avoca State of the Industry Report: Diversity in Clinical Research Execution and Participation
Life Science Leader - By Denise Calaprice, Ph. D., Senior Consultant, WCG Avoca - The events of the past two years created an urgent and nonnegotiable imperative to increase diversity in clinical research: diversity both in how such studies are executed, and in the types of patients recruited for participation […]
Read MoreJune 28, 2022 | 11:00am - 12:00pm EDT
Read MoreJune 16, 2022 | 11:00am - 12:00pm EDT
Read MoreMay 25-26, 2022 | Virtual
Now in its eleventh year, the Avoca Summit focuses on quality and the adoption of innovative technology in the execution of clinical trials.
May 24, 2022 | 1:00pm - 2:00pm EDT
Read MoreMay 1-4, 2022 | Boston, MA + Virtual
Join WCG Avoca for the session: "Sticking Points in Decentralizing Clinical Trials"
April - May 2022 | Virtual
Join Oracle's global community of customer advocates and industry leaders virtually for in-depth discussions about overcoming the challenges of today’s life sciences environment.
April 6, 2022 | 11:00am – 12:00pm EDT
Join us for the next webinar in the Jon Lee series.
March 9, 2022 | 1:30pm - 2:30pm EST
Read MoreDecember 16, 2021 | 11:00am – 12:00pm EST
Join WCG Avoca's next 2021 Jon Lee Series webinar.
December 14, 2021 | 1:00pm – 2:00pm EST
Join WCG Avoca's Patricia Leuchten on a panel discussion hosted by Oracle Health Sciences.
November 2, 4, 9, and 11, 2021 | Virtual
Now in its tenth year, the Avoca Summit focuses on quality and the adoption of innovative technology in the execution of clinical trials.
November 2-4, 2021 | Virtual Event
Join Avoca's session: "Avoca Research on Adoption of Innovation"
September 22, 2021 | 11:00am – 12:00pm EDT
In an increasingly competitive market, how do Sponsor organizations proactively reduce site burden to create more effective and positive relationships with focus on issues that matter?
September 20, 2021
WCG Integrates WCG's Metrics Champion Consortium and WCG Avoca Quality Consortium, Creating Industry's Leading Forum for Clinical Trial Performance Metrics and Quality Management Knowledge Sharing
August 31, 2021 | 1:00 – 2:00 PM EDT
Register for this webinar to hear about the forthcoming ICH guidelines, which renew the focus on efficiencies in conducting clinical trials and provide tools to do so – significantly impacting oversight.
Each year, WCG Avoca surveys industry professionals to understand trends in clinical development, with a particular focus on outsourcing dynamics and relationships between research Sponsors and Providers.
Access The 2020 Avoca State of the Industry Report: Innovation by Fire, Diversity, and the Next Normal
WCG Avoca's Crissy MacDonald, PhD, joins episode 17 of The Latest Dose Podcast by Oracle Health Sciences.
Read MoreLife Science Leader - By Denise Calaprice, Ph. D., Senior Consultant, WCG Avoca - For decades, operational progress within the clinical research industry has been profoundly shaped by the relationships between sponsor companies and their CRO partners. Among other advances, these relationships have contributed to sponsors’ abilities to globalize clinical trial operations, expand […]
Read MoreJune 27 - July 1, 2021 | Virtual
Join Avoca for the session: "Post COVID: Sites Evolving Role in the Clinical Trial Ecosystem"
June 17, 2021 | 11:00am – 12:00pm EDT
How do we finish what COVID started?
In the May 2021 issue of International Clinical Trials, ICT interviews Steve Whittaker at WCG Avoca, who describes how the evolving regulatory landscape of the clinical trial industry stands to spur change in the way we manage data.
Read MoreMay 26, 2021 | 11:00am – 12:00pm EDT
In this webinar, Medable and WCG Avoca share results from the 2020 Avoca State of the Industry Survey and real clinical trial case studies from Medable.
The Avoca Group strengthens WCG’s position as an industry leader for accelerating clinical trial quality management and compliance transformation. WCG™, a leading provider of clinical trial solutions, announced its acquisition of The Avoca Group, a life sciences consulting firm supporting biopharma, biotech, CROs and clinical service providers, […]
Read MoreA consortium model of pharmaceutical players helps The Avoca Group change the clinical trial execution process
Read MoreApril 26 - May 6, 2021 | Virtual
Join Avoca for the session: "Powerful Quality Management Systems for Sponsors, Sites and CROs"
April 15, 2021 | 11:00am – 12:00pm EDT
Ensure you are inspection ready during the changing trial landscape imposed by COVID-19 and resultant adjustments in regulations
April 7-8, 2021 | Virtual
Join Avoca for the session: "Distinguish Key Risk Indicators (KRIs) from Quality Tolerance Limits (QTLs) and Why This is Important"
March 30, 2021 | 1:00 – 2:00pm EDT
ICH E6 (R3) is coming at a time when life science organizations still are struggling to adopt ICH E6 (R2). But should organizations wait until these guidelines are ratified to realize the intended benefits?
Successful performance metrics focus on what drives success across the enterprise. They help answer important questions. They have a purpose. Don’t measure things simply because you can, or that aren’t a concern for your organization. That may sound obvious, but many organizations measure things that simply don’t matter. Just because something is a problem […]
Read MoreSponsors and ECG Core Labs need to effectively manage and track their resources, including people, time, and money, as each has an impact on productivity and efficiency over the course of a clinical trial. This case study demonstrates how Lilly and Quintiles utilized ECG Performance Metrics to have meaningful conversations around performance metrics to […]
Read MoreA clinical-stage biopharmaceutical company requested that Avoca perform an in-depth review and assessment of its Quality Management System (QMS). The project objectives were to identify and document gaps and to provide guidance in the design and development of a comprehensive QMS that would complement the company’s existing QMS. The company also requested that Avoca […]
Read MoreSince the release of ICH (E6) R2 in 2017, clinical research companies have been taking active measures to ensure compliance with its new guidance which, “encourages implementation of improved and more efficient approaches to clinical trial design, conduct, oversight, recording, and reporting while continuing to ensure human subject protection and reliability of trial results.” […]
Read MoreA clinical-stage global biopharmaceutical company with major hubs in the US and Japan requested that Avoca perform an in-depth review and assessment of its Clinical Quality Management System (CQMS) with a special focus on Vendor Oversight, Risk Management, Technology Business Requirements, and Quality Tolerance Limits (QTLs). The project objectives were to identify and document […]
Read MoreBy providing a mid-sized pharmaceutical client with more than a standard mock inspection and having the agility to pivot as the client’s needs changed, Avoca positioned the company for a successful regulatory inspection. Avoca not only delivered clear and actionable findings; it helped the client design and execute a remediation strategy. To download the […]
Read MoreAs the GCP landscape continually evolves, sponsors are encouraged to pursue innovative approaches. Mock Inspections are a critical tool to ensure inspection readiness and a quality control step to confirm that the innovative approaches are being implemented in a regulatorily compliant way. Inspection Readiness needs to keep pace with this philosophy and to be […]
Read MoreAugust, 2016 Just because information can be gathered and shared more quickly among stakeholders does not mean that it can identify risk. This article describes the need for pharma to adopt fully-vetted, standardized operational-level time, cost and quality performance metrics as tools for tracking and predicting performance. The proliferation of cloud-based technologies has made it […]
Read MoreApril 7, 2017 The pharma industry agrees that the importance of entering data into an EDC as soon as possible following a subject is paramount. Slow site data entry can impact the credibility and usefulness of centralized monitoring data analytic reports. But MCC survey indicates poor oversight undermines ability to monitor study quality With the […]
Read MoreJune 15, 2020 - CenterWatch
With the International Council on Harmonization (ICH) poised to begin work on another revision to its good clinical practice (GCP) guideline, ICH E6, sites and sponsors have questions about what they can expect from upcoming changes while they still are struggling to interpret requirements placed on them by the previous 2016 revision. See insights provided by Steve Whittaker, Senior Consultant of The Avoca Group.
June 15, 2020 - CenterWatch
With the International Council on Harmonization (ICH) poised to begin work on another revision to its good clinical practice (GCP) guideline, ICH E6, sites and sponsors have questions about what they can expect from upcoming changes while they still are struggling to interpret requirements placed on them by the previous 2016 revision. See insights provided by Steve Whittaker, Senior Consultant of The Avoca Group.
June 15, 2020 - CenterWatch
With the International Council on Harmonization (ICH) poised to begin work on another revision to its good clinical practice (GCP) guideline, ICH E6, sites and sponsors have questions about what they can expect from upcoming changes while they still are struggling to interpret requirements placed on them by the previous 2016 revision. See insights provided by Steve Whittaker, Senior Consultant of The Avoca Group.
December 2-3, 2020 | Virtual
Join Avoca's session: "ICH E6(R3) Review: RBQM Considerations within Annex 2 Applied to Non-Traditional Trials"
October 14-15, 2020 | Virtual
Now in its ninth year, the Avoca Summit focuses on quality and the adoption of innovative technology in the execution of clinical trials.
Press Release – September 30, 2020 Novo Nordisk was recognized with the ACRP-Avoca Sponsor Quality Award during the ACRP-Avoca Quality Congress this month. The Association of Clinical Research Professionals and The Avoca Group jointly recognized leading sponsors at the event. The following ACRP-Avoca Sponsor Quality Awards were announced: First Place – Novo Nordisk Second Place […]
Read MorePress Release – September 30, 2020 Covance was recognized with the ACRP-Avoca CRO Quality Award during the ACRP-Avoca Quality Congress this month. The Association of Clinical Research Professionals and The Avoca Group jointly recognized leading CROs at the event. The following ACRP-Avoca CRO Quality Awards were announced: First Place – Covance Second Place – ICON […]
Read MoreInc. magazine today revealed that The Avoca Group has been placed on its annual Inc. 5000 list, the most prestigious ranking of the nation’s fastest-growing private companies. The list represents a unique look at the most successful companies within the American economy’s most dynamic segment—its independent small businesses. […]
Read MoreThe Avoca Group announced the agenda for its 2020 Avoca Quality and Innovation Summit. The event, which will be held virtually on October 14–15, will explore the role of quality as the foundation of clinical trials and the need for innovation in study execution. Across two days of interactive sessions, panel discussions, and workshops, attendees […]
Read MoreSeptember 10 and 15, 2020 | Virtual
Join Executive Leadership for this Virtual Program Exploring Patient Centricity in Clinical Trials
September 9, 2020 | 11:00am – 12:00pm EDT
This webinar has been postponed. Please stay tuned for the rescheduled date.
Each year, The Avoca Group surveys industry professionals to understand trends in clinical development, with a particular focus on outsourcing dynamics and relationships between research Sponsors and Providers. Access The 2019 Avoca State of the Industry Report:
Each year, The Avoca Group surveys industry professionals to understand trends in clinical development, with a particular focus on outsourcing dynamics and relationships between research Sponsors and Providers. Access The 2019 Avoca State of the Industry Report:
September 3, 2020 | 11:00am - 12:00pm EDT
Chutes, Ladders, and Unexpected Journeys
August 25, 2020 | 1:00pm – 2:00pm EDT
Read MoreJuly 7, 2020 – Clinical Leader – By Mai Nguyen, Senior Consultant, The Avoca Group – In clinical research, we learn to act instinctively and quickly when it comes to making decisions about subject protection, data validity, and ethical conduct. That skillset inherently comes with the ability for problem-solving with a focused determination on the patient. The […]
Read MoreJune 15, 2020 - CenterWatch
With the International Council on Harmonization (ICH) poised to begin work on another revision to its good clinical practice (GCP) guideline, ICH E6, sites and sponsors have questions about what they can expect from upcoming changes while they still are struggling to interpret requirements placed on them by the previous 2016 revision. See insights provided by Steve Whittaker, Senior Consultant of The Avoca Group.
June 14-18, 2020
The lively panel presentations, insightful Q&A sessions, and deep community exchanges you've come to expect from DIA will be carried on through digital technology.
3-4 June 2020 | Amsterdam
In light of the public health concerns around the spread of COVID-19, The Avoca Group has chosen to reschedule the 2020 Avoca Quality and Innovation Summit originally planned for 3-4 June in Amsterdam. Details to follow.
May 5, 2020 | 11:00am – 12:00pm EDT
The Final Concept Paper for ICH E6(R3), dated 17 November 2019, states, “The action proposed is a full rewrite and reorganization of the ICH E6(R2) Guideline….and will include addressing the application of GCP principles to the increasingly diverse trial types and the data sources being employed to support regulatory and healthcare-related decision-making on drugs, and provide flexibility whenever appropriate to facilitate the use of technological innovations in clinical trials.”
May 2, 2020 | Seattle, WA
Women in Leadership: Chutes, Ladders, and Unexpected Journeys - Executive leadership from Juno Therapeutics, Genentech, IQVIA, The Avoca Group, and Javara Research will share their career journeys and host an honest conversation about what it takes to advance as a woman in research.
May 1, 2020 | Seattle, WA
Adding Electricity to Patient Centricity: Energizing Solutions - Join patients and executive leadership from sponsors, CROs, sites, and technology suppliers in a collaborative, solutions-focused discussion of the patient centricity landscape. Industry leadership will unveil recent trends in the use of patient-centric tools and technologies and lead an […]
April 9, 2020 | 11:00am – 12:00pm EDT
Join Janis Hall, AQC Leadership Advisory Board Members, and fellow AQC Members for the AQC’s first Open Mic session where we will answer questions about Provider Qualification, such as, “What do you share with regulatory inspectors when asked to show evidence of provider prequalification?” and […]
March 25, 2020 – This is an update on how we are addressing the needs of Avoca’s clients and Quality Consortium Members, and the companies that we are working with as part of the Diligent® Qualification Platform, given the extraordinary circumstances that we face with COVID-19. The Avoca Group Operations Avoca and its global team of experts have […]
Read MoreMarch 6, 2020
Washington, DC – The Association of Clinical Research Professionals (ACRP) and The Avoca Group will jointly recognize leading Sponsors and CROs at the ACRP Awards & Recognition Ceremony on Friday, May 1, during the ACRP 2020 annual conference in Seattle, Washington.
March 4, 2020 – Contract Pharma – Jay A. Turpen, Senior Consultant, The Avoca Group – Key first steps to vendor risk management. Are your company’s clinical development vendor qualification (VQ) activities a “Check-The-Box” exercise because someone said that regulators expect it? Or are your VQ activities a comprehensive first step in managing the risk […]
Read More24–25 February 2020 | London
Join Avoca's session, "Define the Framework and Critical Elements of an Effective Oversight Plan: ICH E6 (R2) Requirements for Vendor Oversight."
February 18, 2020 | 11:00am – 12:00pm EST
In this webinar, Crissy MacDonald, Executive Director, Client Delivery, The Avoca Group, will discuss the Quality Tolerance Limit requirements of ICH E6 (R2) and the intersect of Section 3 of ICH E8 (R1), where specific focus is given to proactive quality-by-design in clinical trials, including identifying and managing critical-to-quality factors (CTQs).
February 11, 2020 | 1:00-2:00 pm EST
Join Avoca and Oracle Health Sciences to identify what's needed to mitigate risk and ensure regulatory compliance and audit-readiness in clinical trials.
January 29, 2020 | 11:00am – 12:00pm EST
Sponsor Responsibilities for Quality Management (Section 5.0 of ICH E6 (R2)) requires that Sponsors oversee trial-related duties and functions, including those that are subcontracted by CROs (5.2.2). Quality assurance has changed from assurance of conformity to the assurance that process performance and quality are managed over […]
January 9, 2020 – GLOBE NEWSWIRE PRINCETON, NJ – A new report from Tufts Center for the Study of Drug Development establishes benchmarks for the vendor qualification process, a critical element of clinical trial set up and execution. According to its November/December Impact Report, the process volume and complexity of the vendor qualification process creates […]
Read MoreDecember 11, 2019 | 11:00am-12:00pm EST
RBQM: The AQC’s Risk-Based Monitoring Framework and Monitoring Plans Consistent with New FDA Draft Guidance
December 2-3, 2019 | Sonesta Hotel | Philadelphia, PA Virtual clinical trials bring the clinical trial experience to the patient. Through these VCTs, companies are expected to reduce trial costs and increase patient enrollment and participation. There are new technologies that make these trials easier to conduct and with the patient demand for more flexibility in their participation, this new way of doing business will only continue to expand for the industry. […]
Read MoreNovember 14, 2019 - Tufts CSDD Study Identifies Opportunities for Drug Sponsors to Optimize Vendor Selection
Read MoreNovember 2019 In the Spotlight article published November 2019 by International Clinical Trials, Patricia (Patty) Leuchten, Founder and CEO of The Avoca Group, reflects on the challenges associated with managing risks and designing quality into clinical trials; the work the Avoca Quality Consortium® has done to bring together industry experts from pharma, biotech, and CROs […]
Read MoreNovember 7, 2019 | Seattle, WA
Attendance at the Fall Member Meeting is one of many benefits of Membership of the Avoca Quality Consortium. Participants gain practical knowledge and experience in a casual, interactive learning environment.
October 30, 2019 | 11:00am – 12:00pm EDT
In this webinar, Dennis Salotti, Chief Operating Officer of The Avoca Group, will present the current state of industry adoption of technologies enabling decentralized clinical trials and discuss perceptions of the challenges, risks, opportunities, and impact as captured by Avoca’s 2018 industry research into this topic. […]
October 29, 2019 | 1:00pm – 2:00pm EDT
Decentralized Clinical Trials (DCTs) offer a more patient-centric approach in which fewer clinic visits are required and patient and caregiver burden are reduced. DCTs utilize a wide range of digital technologies to collect safety and efficacy data from study participants, normally remotely from the patient’s own home. […]
October 16-18, 2019 | Sonesta Hotel | Philadelphia, PA The CQOF has become THE annual event for clinical quality professionals to network with, learn from and benchmark against their peers. The CQOF provides an interactive forum for senior-level clinical quality and operations professionals to engage, discuss and share their challenges, best practices and experiences in […]
Read MoreSeptember 13, 2019 – Applied Clinical Trials – Dennis Salotti, COO, The Avoca Group – Each year, The Avoca Group invites clinical trial professionals from sponsor and provider organizations to participate in research on prescient industry topics and to provide key benchmarks on the current state of clinical outsourcing. For this year’s report, Avoca analyzed data […]
Read MoreSeptember 9, 2019 | 11:00am – 12:00pm EDT
Accelerate Clinical Trial Execution with New AQC Kickstart Package
August 26, 2019 – ClinicalLeader.com – Ed Miseta, Chief Editor, Clinical Leader – Each year, The Avoca Group surveys industry professionals to understand trends in clinical development. The surveys place a particular focus on outsourcing dynamics and relationships between sponsor companies and service providers. For one of its most recent surveys, Avoca examined what sponsors and […]
Read MoreAugust 15, 2019 – ClinicalLeader.com – By Dennis Salotti, COO, The Avoca Group – Our global digital population – people around the world that are active internet users – has grown to 4.3 billion as of July 2019, representing roughly 56 percent of the global population. […]
Read MoreAugust 14-15, 2019 | Sonesta Hotel | Philadelphia, PA The Avoca Group is pleased to once again be speaking at ExL’s 8th Clinical Trials Inspection Readiness Summit, August 14-15, in Philadelphia, PA. By attending the Summit, you will understand the importance of an organizational culture of inspection readiness and how to implement that cultural change. […]
Read MoreAugust 8-9, 2019 | The Inn at Penn | Philadelphia, PA Please join Avoca at T3: Trials, Tech and Transformation where we will be speaking and participating on a panel. T3 provides a platform to industry insights and patient perspectives on the major shifts occurring within the clinical trial space. By attending, you will gain insight […]
Read MoreJuly 18, 2019 | 11:00am – 12:00pm EDT
Periodic screenings are an important part of inspection readiness. In this presentation, we’ll discuss the benefits of an ongoing state of inspection readiness throughout a trial, where hidden challenges lurk in an inspection, and how mock inspections can bring these issues to light.
So often, inspections are a major source of stress in the clinical trial environment. This is especially true when processes involved in preparing for an inspection are reactive. But, it doesn’t have to be that way. Using industry-leading practices and resources enables a proactive approach to mitigate—or even eliminate—the pain points associated with preparing […]
Read MoreJune 23-27, 2019 | San Diego, CA The DIA 2019 Global Annual Meeting brings together thousands of innovators from around the globe. Designed to drive insights into action by connecting key policy discussions to real-world knowledge that you need to do your job every day, your attendance will accelerate your growth and your organization’s […]
Read MoreJune 5-6, 2019 | Boston, MA
With over a dozen interactive sessions and numerous networking opportunities, the Summit offered attendees a chance to connect, address challenges, engage with thought leaders, and influence global change. For a recap of the event, click Read More below.
May 29, 2019 — Dublin, Ireland — AP News — Longboat Clinical is pleased to announce a new partnership with the Avoca Quality Consortium (AQC) to make an extensive suite of quality management tools available to hospitals and clinics participating in clinical studies. The AQC, a precompetitive collaborative comprised of nearly 100 pharma, biotech, CRO, and […]
Read MoreMay 21-22, 2019 | King of Prussia, PA Arena International’s Outsourcing in Clinical Trials East Coast will be co-located with Clinical Technology and Data Management East Coast in King of Prussia for its 10th Annual event! The 2019 programme boasts a range of speakers. Through a variety of interactive session formats, the agenda focusses on […]
Read MoreExamines vendor qualification process, company experience managing this process and ways that it can be improved May 15, 2019 – Contract Pharma – The Center for the Study of Drug Development, an independent, academic, non-profit research group within Tufts University School of Medicine, in collaboration with the Avoca Group, is conducting a survey examining the vendor […]
Read MoreMay 13-15, 2019 | Boston, MA The Avoca Group is pleased to once again be speaking at CHI’s 8th Clinical Trials Innovation Summit, May 13-15, in Boston, MA. The Summit brings together 300+ leaders from across pharma, biotech and academia for the perfect blend of high quality presentations and intimate networking. Through case studies, interactive discussions […]
Read MoreMay 9, 2019 – Princeton, NJ – (BUSINESS WIRE) – The Avoca Group announced today that David Shing, Verizon Media’s Digital Prophet, will deliver the keynote address at the 8th Annual Avoca Global Summit. David will discuss current and future trends in the evolving digital landscape, including how the rapid adoption of technology will advance […]
Read MorePress Release – April 13, 2019 Washington, DC – Roche/Genentech was recognized with the ACRP-Avoca Sponsor Quality Award yesterday during the ACRP-Avoca Awards and Recognition Ceremony taking place at the ACRP 2019 annual conference. The Association of Clinical Research Professionals and The Avoca Group jointly recognized leading sponsors at the event. The following ACRP-Avoca Sponsor […]
Read MorePress Release – April 13, 2019 Washington, DC – PPD was recognized with the ACRP-Avoca CRO Quality Award yesterday during the ACRP Awards and Recognition Ceremony taking place at the ACRP 2019 annual conference in Nashville. The Association of Clinical Research Professionals and The Avoca Group jointly recognized leading CROs at the event. The following […]
Read MoreApril 12, 2019 | The Omni Nashville Hotel | Nashville, TN Quality and Risk Management through Industry Collaboration Back for its second year, the ACRP Quality Congress provides an unparalleled view of the changing clinical trial landscape and offers exclusive networking opportunities with management teams from sponsors, CROs, and sites. This half-day program will […]
Read MoreBy Steven B. Whittaker and Janis L. Hall, The Avoca Group ClinicalLeader.com – April 11, 2019 Developing new, innovative pharmaceutical agents to address global health needs is becoming more complex, challenging, and costly. As the industry attempts to adapt and gain value for patients, healthcare providers, and other stakeholders, technologies, digitization, real-world data, immediate […]
Read MoreMarch 19, 2019 – Princeton, NJ – The Avoca Group today announced the preliminary agenda for its 8th Annual Avoca Global Summit to be held June 5-6 at the Boston Harbor Hotel in Boston, MA. […]
Read MoreMarch 18-20, 2019 | The Inn at Penn | Philadelphia, PA Now in its tenth year, ExL’s Proactive GCP Compliance conference continues to act as the annual forum for both senior-level clinical quality and clinical operations executives to gather, learn and discuss strategies to achieve and maintain global GCP compliance. Join us to learn how […]
Read MoreFebruary 25-26, 2019 | Hilton London Canary Wharf | London, UK The European Clinical Quality Oversight Forum in London is the ONLY European event dedicated to risk-based approaches for selecting, managing and monitoring clinical vendors and sites. This interactive event focuses on ensuring trial integrity by effectively assessing, optimising and managing the quality of clinical […]
Read MoreFebruary 13, 2019 | 11:00am - 12:00pm EST
Learn leading practices for a comprehensive risk-based approach to implementing and living in an ongoing, risk-based culture through the minimization of active, high resource-consuming issues.
January 29, 2019 | 10:30am - 11:30am EST
This webinar will review practical steps to reaching and maintaining a confident level of risk-based inspection readiness using vendor oversight as an area of focus.
January 22-24, 2019 | Hilton Orlando Lake Buena Vista | Orlando, FL Learn more >> 15% off standard pricing rates using Discount Code AVOCAVIP Join Avoca for the following session: Thursday, January 24 – 9:10am | Main Conference Day Two [Panel] Prepare for a TMF Inspection With a Quality Management System Manifest prioritization drivers […]
Read MoreJanuary 22-24, 2019 | Hilton Orlando Lake Buena Vista | Orlando, FL CROWN provides a comprehensive education on the latest strategies, trends, tools, and technologies for optimizing clinical trials and enables you to make the connections necessary to streamline operations and advance. In 2019, the 8th Crown Congress will expand on last years conference by […]
Read MoreJanuary 9, 2019 | 11:00am – 12:00pm EST
Presented by Steve Whittaker and Jay Turpen, this interactive webinar will clarify terminology, including metrics, performance indicators, and tolerance limits.
By Steve Whittaker, Senior Consultant, The Avoca Group ClinicalLeader.com – January 8, 2019 The International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) E6(R2) regulations have created a buzz within the industry regarding newly required expectations for quality tolerance limits (QTLs) when conducting good clinical practice (GCP) clinical trials. QTLs […]
Read MoreBy Crissy MacDonald, PhD, Executive Director, Client Delivery, The Avoca Group Outsourcing-Pharma.com – December 13, 2018 2018 was a pivotal year for the pharmaceutical industry and the execution of clinical trials. In November 2016, for the first time in more than 20 years, the ICH E6 Good Clinical Practice (GCP) Guideline was amended, and […]
Read MoreTORONTO, December 13, 2018 (Newswire.com) – Expectations for quality tolerance limits when conducting Good Clinical Practice (GCP) clinical trials in accordance with ICH E6(R2) have generated a buzz in the industry. Quality tolerance limits have historically been required for Good Manufacturing Practice (GMP) activities, inferring limits by which significant actions must be taken to ensure the manufactured product achieves quality and usability limits. With regulators now […]
Read MoreDecember 12, 2018 | 2:00pm - 3:00pm EST
This webinar will focus on leading practices within the AQC Knowledge Center that align with findings of Avoca/ACRP research. We will also share tools AQC Members have developed to help sites build or enhance their Quality Management System.
Clinical Leader – December 6, 2018 A conversation with Jim Kremidas of ACRP and Dennis Salotti of The Avoca Group The Association of Clinical Research Professionals (ACRP) and The Avoca Group surveyed nearly 300 clinical trial study site staff earlier this year to determine the most important factors for advancing quality in studies from […]
Read MoreNovember 28, 2018 | 10:00am - 11:00am EST
Attend this webinar to learn about the various regulatory expectations of TMFs. Presented by Terry Endress.
November 20, 2018 | 11:00am – 12:00pm EST
Avoca and ACRP will discuss results of industry research that showed what makes sponsors and CROs “partners of choice” with sites.
This Webinar will be hosted by Xtalks.
November 12, 2018 | 11:00am – 12:00pm EST
The Avoca Quality Consortium will showcase the most frequently downloaded leading practices from its Knowledge Center (library of leading practices) and the most active online community discussions among Members.
October 30, 2018 | Princeton, NJ
Attendance at the Fall Member Meeting is one of many benefits of Membership of the Avoca Quality Consortium. Participants gain practical knowledge and experience in a casual, interactive learning environment.
October 26, 2018 — In early 2018, The Avoca Group and the Association of Clinical Research Professionals (ACRP) collaborated on web-based survey research to evaluate the key attributes that drive quality in clinical trials from the site perspective. In the research, investigational sites were asked to rate sponsor and CRO attributes (including responsiveness to questions, […]
Read MoreOctober 16, 2018 — BlueCloud by HealthCarePoint (HCP), a Texas-based healthcare and clinical research networking-technology company founded by patient-survivors, and The Avoca Group, Inc., a life sciences consulting firm dedicated to improving quality and compliance in the clinical trial execution process, today announced its mutual collaboration […]
Read MoreOctober 10-12, 2018 | Philadelphia, PA
Attend a presentation by Steve Whittaker, “The Impact of (R2) Sites,” and a panel discussion, “Inspection of Oversight Activities.”
September 26, 2018 Princeton, NJ – Including clinical research sites in regulatory inspection preparedness planning is among the most effective actions sponsors and CROs can take to build positive relationships with sites, according to a new white paper, “Becoming a Sponsor/CRO of Choice: The Site Perspective,” released today by the Association of Clinical Research […]
Read MoreThe survey is now closed. Are you a clinical research Sponsor with experience in emerging data sources and technologies in clinical trials? If so, we invite you to participate in the 2018 Avoca Industry Survey. As a way of saying thank you, you’ll receive an advance, complimentary copy of the research results PLUS the choice […]
Read MoreThe survey is now closed. Are you a clinical research Provider with experience in emerging data sources and technologies in clinical trials? If so, we invite you to participate in the 2018 Avoca Industry Survey. As a way of saying thank you, you’ll receive an advance, complimentary copy of the research results PLUS the choice […]
Read MoreThe survey is now closed. As a clinical research professional with valuable knowledge and insights to share from the Site’s perspective, we invite you to participate in the 2018 Avoca Industry Survey. The survey takes 10 minutes, and as a way of saying thank you, you’ll receive an advance, complimentary copy of the research results […]
Read MoreSeptember 25, 2018 | 11:00-12:00 EDT
Presented by Crissy MacDonald, Executive Director, Client Delivery, The Avoca Group, and Jeff Kingsley, CEO, IACT Health.
September 14, 2018 | 11:00am - 12:00pm EDT
Knowledge Center Provider Qualification Overview
By Crissy MacDonald, PhD, Executive Director, Client Delivery, The Avoca Group Applied Clinical Trials – August 23, 2018 Although the pharmaceutical industry has always incorporated risk-based processes, the ICH E6 (R2) addendum now mandates that clinical trial operations also include risk-based approaches. Based on the latest research, and The Avoca Group’s experience helping companies […]
Read MoreAugust 13-14, 2018 | Philadelphia, PA
Attend a presentation entitled, “Comparing how agencies (FDA, EMA, MHRA, Health Canada, PMDA, and CFDA) conduct inspections. What are the implications of ICH E6 (R2), based on recent inspection experiences?"
July 25, 2018 | 11:00-12:00 EDT
Back by popular demand. Co-hosted by Steve Whittaker, Senior Consultant and Executive Director, The Avoca Group, and Grace Crawford, VP of Clinical Quality and Compliance, MedImmune.
By Ed Miseta, Chief Editor, Clinical Leader Clinical Leader – July 9, 2018 We all know the days of Big Pharma companies launching billion-dollar blockbuster drugs are generally behind us. Today, novel new therapies are harder to bring to market. Trials are costly, take a long time to complete, and too many of them […]
Read MorePress Release – June 13, 2018 Princeton, NJ. The Avoca Group announced today that it has launched the Diligent® Qualification Platform, the clinical research industry’s first centralized platform for vendor qualification as well as eLuminate™, an online […]
Read More13-14 June 2018 | Dublin, Ireland
Join your peers for two insightful days of high-quality analyses and discussions focused on transforming clinical trial execution. Avoca will also unveil two new technology platforms.
Press Release – June 6, 2018 Princeton, NJ. The Avoca Group announced today that Dr. Jeff Kasher has assumed the role of Executive Chair for the Avoca Quality Consortium (AQC), its member-based industry collaborative focused on driving efficiency, improving quality, and mitigating risk in clinical trial execution. The AQC is comprised of clinical operations, quality, […]
Read MorePress Release – May 23, 2018 Princeton, NJ – The Avoca Group has announced the full speaker lineup for the 7th Annual AQC® Global Quality Summit, taking place 13-14 June 2018 in Dublin, Ireland. The theme for this year’s event – Embrace the Present. Own the Future. – focuses on today’s most innovative solutions for […]
Read MoreMay 9-10, 2018 | Philadelphia, PA
Patricia Leuchten, CEO, The Avoca Group, will participate in a panel discussion with SCRS, ACRO, ACRP, and APCR on Wednesday, May 9.
May 7-9, 2018 | Boston, MA
Dennis Salotti, VP of Operations, The Avoca Group, will participate on the panel discussion, “Balancing Oversight in the Wake of ICH E6 (R2)” in the track, Vendor Quality, Performance and Oversight.
May 3, 2018 | 1:00pm – 2:00pm EDT
In this webinar, leading practices for proactive study startup planning will be shared. Participants will learn how to effectively deliver on improved overall study quality while supporting regulatory compliance for provider oversight.
By Dennis Salotti, COO, The Avoca Group Clinical Leader – May 1, 2018 Recent revisions to the International Council for Harmonisation (ICH) Guideline for Good Clinical Practice, as outlined in ICH E6 (R2), have provided an impetus for sponsors to reevaluate their oversight and quality management processes throughout the clinical development process. Specifically, ICH […]
Read MorePress Release – April 27, 2018 Medpace was recognized with the first-ever ACRP-Avoca CRO Quality Award today during the ACRP-Avoca Awards and Recognition Ceremony taking place at the ACRP 2018 annual meeting. The Association of Clinical Research Professionals and The Avoca Group jointly recognized leading CROs at the event. The following ACRP-Avoca CRO Quality Awards […]
Read MorePress Release – April 27, 2018 Abbott Laboratories was recognized with the first-ever ACRP-Avoca Sponsor Quality Award today during the ACRP-Avoca Awards and Recognition Ceremony taking place at the ACRP 2018 annual meeting. The Association of Clinical Research Professionals and The Avoca Group jointly recognized leading sponsors at the event. The following ACRP-Avoca Sponsor Quality […]
Read MoreApril 27, 2018 | National Harbor, MD
In conjunction with the ACRP Annual Meeting and the Avoca Quality Consortium®, this one-day event will offer participants an unparalleled view of the changing clinical trial landscape and transformational approaches to improving clinical research quality.
April 17, 2018 | 11:00am - 12:00pm EDT
Knowledge Center Patient Engagement Overview
March 21, 2018 | 11:00am - 12:00pm EDT
Inspection Preparation With a Risk-Based Approach Consistent with ICH E6 (R2) Requirements
March 19-21, 2018 | Philadelphia, PA
Join Avoca for a presentation outlining a practical approach for identifying and measuring risk in clinical trial operations.
By Cristin MacDonald, PhD, Executive Director of Client Delivery, The Avoca Group Clinical Leader – March 15, 2018 The purpose of a comprehensive assessment system is to support structured, systematic, objective, and rational decision making. This holds true even when assessing something as difficult to pin down as risk. The Avoca Quality Consortium (AQC) takes […]
Read MoreBy Andrew Burrows, KNect365 KNect365 Life Sciences – March 14, 2018 KNect365 spoke to Patricia Leuchten, President and CEO at The Avoca Group, as part of PCT TV at Partnerships in Clinical Trials Europe (Nov 2017) about how the clinical trials industry should interpret the ICH E6 R2 guidelines and the biggest challenges to […]
Read MorePress Release – March 13, 2018 Princeton, NJ – The Avoca Group announced today that it will unveil the Diligent® Qualification Platform as well as eLuminate™, an e-learning platform, at the 7th Annual Global Quality Summit 13-14 June 2018, at the Hotel Intercontinental in Dublin, Ireland. Sponsored by the Avoca Quality Consortium® (AQC), a Member-based […]
Read MorePress Release – March 13, 2018 The Association of Clinical Research Professionals (ACRP) and The Avoca Group will jointly recognize leading Sponsors and CROs at the ACRP/Avoca Awards & Recognition Ceremony on Friday, April 27, during the ACRP 2018 annual meeting. Finalists for the ACRP-Avoca Quality Awards were chosen by investigational sites through a research […]
Read MoreMarch 8, 2018 | 11:00am-12:00pm EST
This webinar will review the key changes for ICH E6 (R2) and discuss the challenges organizations are facing to adapt current practices to be compliant with the amended regulations.
February 26-27, 2018 | London, UK
Join Avoca as we present on Service Provider Prequalification: Centralizing qualification to drive consistency, efficiency, and higher quality.
February 21, 2018 | 11:00am-12:00pm EST
In this Webinar, we’ll discuss how centralizing clinical service provider qualification activities results in consistency, efficiency, and higher quality.
January 23-25, 2018 | Philadelphia, PA
Join Avoca as we present sessions on a Clinical Quality Risk Management System (CQRMS) with Inovio and developing effective oversight strategies, and lead a panel discussion on outsourcing in clinical trials.